uniQure (QURE) Q3 2026 Earnings Call Transcript
Huntington's gene therapy heads toward FDA review with a launch plan taking shape.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
Huntington's gene therapy heads toward FDA review with a launch plan taking shape.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Record concerts and a Harry Styles run powered a strong quarter.
First full quarter of Lumvoa sales beat expectations as patient starts accelerated.
Growth from new contracts and a $1 billion buyback shaped the quarter.
Record cash flow meets a long wait for Keno Hill permit approvals.